<--- Back to Details
First PageDocument Content
Carcinogenesis / Cancer research / Metastatic breast cancer / Angiogenesis / Enhanced permeability and retention effect / Vascular endothelial growth factor / Metastasis / Circulating tumor cell / Prostate cancer / Medicine / Oncology / Angiology
Date: 2014-09-08 14:26:00
Carcinogenesis
Cancer research
Metastatic breast cancer
Angiogenesis
Enhanced permeability and retention effect
Vascular endothelial growth factor
Metastasis
Circulating tumor cell
Prostate cancer
Medicine
Oncology
Angiology

PS-OC Program Quarterly Publication Highlights: September 2014 Broken nuclei – lamins, nuclear mechanics, and disease. Davidson PM, Lammerding J. Trends Cell Biol[removed]): [removed]This review provides a comprehens

Add to Reading List

Source URL: opso.cancer.gov

Download Document from Source Website

File Size: 499,21 KB

Share Document on Facebook

Similar Documents

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

DocID: 1v2t4 - View Document

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

DocID: 1t4Bh - View Document

Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

DocID: 1sS2d - View Document

Theranostics 2016, Vol. 6, Issue 11  Ivyspring International Publisher  Research Paper

Theranostics 2016, Vol. 6, Issue 11 Ivyspring International Publisher Research Paper

DocID: 1qwzN - View Document

APPLI CATI O N N O T E  Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

APPLI CATI O N N O T E Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

DocID: 1q7G9 - View Document